» Articles » PMID: 33148662

Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 2020 Nov 5
PMID 33148662
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive lobular breast carcinoma (ILC), one of the major breast cancer histologic subtypes, exhibits unique features compared with the well-studied ductal cancer subtype (IDC). The pathognomonic feature of ILC is loss of E-cadherin, mainly caused by inactivating mutations, but the contribution of this genetic alteration to ILC-specific molecular characteristics remains largely understudied. To profile these features transcriptionally, we conducted single-cell RNA sequencing on a panel of IDC and ILC cell lines, and an IDC cell line (T47D) with CRISPR-Cas9-mediated E-cadherin knockout (KO). Inspection of intracell line heterogeneity illustrated genetically and transcriptionally distinct subpopulations in multiple cell lines and highlighted rare populations of MCF7 cells highly expressing an apoptosis-related signature, positively correlated with a preadaptation signature to estrogen deprivation. Investigation of E-cadherin KO-induced alterations showed transcriptomic membranous systems remodeling, elevated resemblance to ILCs in regulon activation, and increased sensitivity to IFNγ-mediated growth inhibition via activation of IRF1. This study reveals single-cell transcriptional heterogeneity in breast cancer cell lines and provides a resource to identify drivers of cancer progression and drug resistance. SIGNIFICANCE: This study represents a key step towards understanding heterogeneity in cancer cell lines and the role of E-cadherin depletion in contributing to the molecular features of invasive lobular breast carcinoma.

Citing Articles

Intricate ribosome composition and translational reprogramming in epithelial-mesenchymal transition.

Morin C, Baudin-Baillieu A, Nguyen Van Long F, Isaac C, Bidou L, Arbes H Proc Natl Acad Sci U S A. 2024; 121(50):e2408114121.

PMID: 39636864 PMC: 11648652. DOI: 10.1073/pnas.2408114121.


Oncogenic composite mutations can be predicted by co-mutations and their chromosomal location.

Kucukosmanoglu A, van der Borden C, de Boer L, Verhaak R, Noske D, Wurdinger T Mol Oncol. 2024; 18(10):2407-2422.

PMID: 38757376 PMC: 11459034. DOI: 10.1002/1878-0261.13636.


Diversity of Intercellular Communication Modes: A Cancer Biology Perspective.

Ebrahim T, Ebrahim A, Kandouz M Cells. 2024; 13(6.

PMID: 38534339 PMC: 10969453. DOI: 10.3390/cells13060495.


Flexiplex: a versatile demultiplexer and search tool for omics data.

Cheng O, Ling M, Wang C, Wu S, Ritchie M, Goke J Bioinformatics. 2024; 40(3).

PMID: 38379414 PMC: 10914444. DOI: 10.1093/bioinformatics/btae102.


The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.

Zhang H, Gao M, Zhao W, Yu L Breast Cancer Res. 2023; 25(1):129.

PMID: 37885030 PMC: 10601136. DOI: 10.1186/s13058-023-01731-3.


References
1.
La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V . RNA velocity of single cells. Nature. 2018; 560(7719):494-498. PMC: 6130801. DOI: 10.1038/s41586-018-0414-6. View

2.
Gao R, Davis A, McDonald T, Sei E, Shi X, Wang Y . Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet. 2016; 48(10):1119-30. PMC: 5042845. DOI: 10.1038/ng.3641. View

3.
Bergen V, Lange M, Peidli S, Wolf F, Theis F . Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol. 2020; 38(12):1408-1414. DOI: 10.1038/s41587-020-0591-3. View

4.
Sikora M, Jacobsen B, Levine K, Chen J, Davidson N, Lee A . WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines. Breast Cancer Res. 2016; 18(1):92. PMC: 5028957. DOI: 10.1186/s13058-016-0748-7. View

5.
Lombaerts M, van Wezel T, Philippo K, Dierssen J, Zimmerman R, Oosting J . E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006; 94(5):661-71. PMC: 2361216. DOI: 10.1038/sj.bjc.6602996. View